Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
9/24/2014
What is the business case for green production in the market for global health aid?
Table of Contents
EXECUTIVE SUMMARY ................................................................
................................ ................................................................
................................ ................................................................
................................ ...................................
................................ ... 2
PART 1: PRESENTATIONS
PRESENTATIONS ................................................................
................................ ................................................................
................................ ...............................................................
................................ ............................... 3
Roads to Transformational Partnership .............................................................................................................3
Methodology for limiting water use in the production of pharmaceuticals .........................................................3
Cradle to Cradle ...............................................................................................................................................4
Joint UN Programme: Greening Procurement in the Health Sector ......................................................................5
PART 2: PANEL DISCUSSION
DISCUSSION - WHAT IS THE BUSINESS CASE FOR GREEN PRODUCTION
PRODUCTION IN THE MARKET FOR
GLOBAL HEALTH AID? ................................................................
................................................................................................
................................................................
................................ ................................ ...................................
................................ ... 6
Panelists: .........................................................................................................................................................6
Introduction by Dr. Christoph Hamelmann........................................................................................................6
Panel Discussion, part 1 ...................................................................................................................................6
Panel Discussion, part 2 ...................................................................................................................................8
PART 3: WORKSHOP - COLLABORATIVE APPROACHES
APPROACHES TO SUSTAINABLE TRANSITION .......................................
................................ ....... 10
Case presentation, Coloplast ..........................................................................................................................10
Case presentation, Novo Nordisk ...................................................................................................................11
Conclusions, group discussions .....................................................................................................................11
CONCLUDING REMARKS ................................................................
................................ ................................................................
................................ ..............................................................
................................ .............................. 14
FUTURE ACTIONS ................................................................
................................ ................................................................
................................ ................................................................
................................ .......................................
................................ ....... 15
LINKS ................................................................
................................ ................................................................
................................ ................................................................
................................ ........................................................
................................ ........................ 16
APPENDIX 1. AGENDA ................................................................
................................ ................................................................
................................ ................................................................
................................ .................................
................................ . 17
APPENDIX 2. PARTICIPANT
PARTICIPANT LIST ................................................................
................................................................................................
................................ ...................................................
................................ ................... 18
What is the business case for green production in the market for global health aid?
EXECUTIVE SUMMARY
UNDP and UNFPA hosted a working session on the 24th September 2014 on the topic What is the business case
for green production in the market for global health aid?, as a part of the joint UNICEF, UNFPA and WHO
meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products
and active pharmaceutical ingredients. The aim of the session was to engage in a dialogue with key
stakeholders with an influence over procurement activities in the health sector, in line with Output 3 of the
Programme document of the Joint UN Initiative on Greening Procurement in the Health Sector. More specifically,
this dialogue includes suppliers/manufacturers, procurement institutions, international health development and
funding agencies, and other relevant stakeholders in the market for global health aid. Overall, through the
involvement of 65 participants, there was a substantial representation of different stakeholders, enabling the
initiation of discussions and engagements around green procurement and production practices in the health
sector.
To enrich the dialogue, prominent organisations such as the Stockholm International Water Institute and the
Environmental Protection Encouragement Agency introduced methodologies for increasing resource efficiency in
production practices, showcasing not only environmental and social benefits of green initiatives, but also the
high financial returns on investments that these would bring. Furthermore, a highly constructive and solutionoriented
panel
discussion
moderated
by
UNDP
demonstrated
clearly
that
purchasers
and
suppliers/manufacturers in the global health aid market are willing to act on greening their practices, and to
start a results-oriented engagement process under the leadership of the UN. The institutions and organisations
represented on the panel were Health Care Without Harm, Novo Nordisk, UNFPA, The Global Fund to fight AIDS,
Tuberculosis and Malaria, International Institute for Sustainable Development and Lupin Limited. Lastly, an
intensive workshop session opened an all-encompassing dialogue between the various participants (including
UN Suppliers, best practice suppliers, procurement institutions, international health development and funding
agencies) to discuss opportunities, challenges and next steps in the movement towards greening production in
the health sector.
The session provided evidence of the following:
UN suppliers of pharmaceuticals and medical devices are ready to become involved in pilot projects on
eco-innovation;
Suppliers are willing to develop eco-innovative products and to work with the UN and other
procurement agencies towards tender processes that take environmental aspects into consideration;
Procurement agencies recognize the importance of the Joint UN Programme on Greening Procurement in
the Health Sector and will show their full support by encouraging and committing to activities proposed
by its Secretariat;
There is an overall consensus among actors to continue the dialogue as soon as possible and to identify
structured forms of engagement for greening production within the market for global health aid.
Page 2
What is the business case for green production in the market for global health aid?
PART 1: PRESENTATIONS
Moderated by: Dr. Pauline Gthberg, National coordinator Swedish County Councils and Regions
Procurement is ever more being used as a policy tool to achieve a sustainable development. When procuring
goods and services for the health sector, this is of utmost importance as there are numerous environmental and
social concerns related to this specific area1. Today, as further knowledge surfaces about these challenges,
words have to be put into action. The joint UN initiative on Greening Procurement in the Health Sector is
working on involving corporations and other stakeholders to encourage such action, in order to influence
development in a positive direction.
During the session, five speakers shared potential solutions to some of these challenges and provided insights
to some true business cases for it, i.e. on how green solutions and green procurement in the health sector can
offer so called win-win scenarios.
R oa d s to Tr an sf o r ma tio n al P ar tn er sh i p
Presented by: Ms. Pernille Fenger, Director UNFPA Nordic Office
The private sector can partner with UN agencies in order to support and join various global initiatives. A number
of concrete ways in which partners can choose to support UN agencies are presented from a UNFPA perspective:
1.
2.
Joint advocacy: a company in a program country can, together with a selected UN agency, advocate for a
3.
Employee programs:
programs Typically focuses on a specific cause and can for example include the organization
example, a mobile company donated mobile phones to UNFPA now being used to trace Ebola.
specific cause.
of fund-raising activities and/or presentations involving UN agencies.
4.
CauseCause-related initiatives: UNFPA examples of cause-related initiatives include the Body Shop and the
Swedish jewelry company Sn which both donate a share of their profits to UNFPAs work to end child
marriage and female genital mutilation in Ethiopia.
5.
Workplace programs:
programs For companies that have production in partner countries, collaborations can be
established to develop workplace programs. In the case of UNFPA, programs have included informing
about sexual transmitted diseases and contraceptives, and preventing gender-based violence.
6.
7.
Volunteering staff:
staff A partnership can also implicate volunteering staff for a certain period of time to one
of the UN offices.
What is the business case for green production in the market for global health aid?
joined STWI. The project guidelines cover three areas: water efficiency, water pollution prevention and
wastewater. SIWI has correspondingly introduced a pharma dialogue, an initiative that was launched in April
2014 in order to reduce the negative impact that production of pharmaceuticals and medical equipment have on
the environment. To advance this agenda, SIWI has now entered into discussions with UNDP and UNFPA on
starting an initiative on water and energy efficiency within the health sector. Health care product suppliers were
openly invited to join pilot projects in reducing water usage, energy efficiency, chemicals and wastewater in
their production, realizing a potential triple win of financial, environmental and social benefits. During the
working session, questionnaires were distributed to explore potential cooperation interest among suppliers for
such an integrated resource management program in the pharmaceutical industry.
Viewing water as a carrier or medium (and not water as a resource) puts water in a new light, steering the
conversation of water and energy efficiency into integrated resource management and change management,
driving a change in mind set. This approach reveals the value of the nexus between (1) water and energy, and
(2) water, chemicals and waste. SIWIs partner, cKinetics has developed these two concepts that help uncover
focus areas when connecting water with other resources: Value-Added Water (VAW) where water is seen as a
carrier (and thereby priced accordingly), or Embodied Value of Water (EVW) to identify products that are at-risk
as water gets scarce. In previous projects conducted in the textile sub-segment, short term savings were made
from low hanging efficiency measures (10-15 %), generating momentum for longer-term savings from process
measurement and process innovations (5-10%).
Cr a dl e t o C ra dl e
Presented by: Mr. Ingo Walterscheid, CEO Environmental Protection Encouragement Agency
The Environmental Protection Encouragement Agency (EPEA) is a worldwide operating research and consulting
institute, founded 27 years ago, that optimizes the quality and usefulness of materials, products and services
through eco-effective design. Its highest ambition is the manufacturing of healthy and environmentally
beneficial products, instead of just reducing harmful substances. EPEA`s core competence is integrating science
with industrial innovation to recreate materials, products and supply chain partnerships so they have positive
impacts. Instead of using todays economic growth model with its linear material flows of products and
processes, the Cradle to Cradle Design framework, as basis of the circular economy, envisions transformation
into cyclical nutrient flows, making initially created value continuously available to human beings and nature.
For the economy this doesnt mean producing less, but rather producing more intelligently.
While the (packaging-) industry has done a lot in the past to minimize its environmental impact, it needs to
focus less on minimizing and more on celebrating its functionality, quality and design. Packaging today is
supposed to be convenient: practical, durable, re-sealable, protective of the contents; as well as visually striking
to attract customers and sell advertising space.
contains a lot of different substances such as plasticizers, pigments, lubricants, antistatic agents, catalysts,
fillers, binders, antioxidants etc.: What do we know about them and their potential effects?
From a Cradle to Cradle perspective packaging is generally not well defined within the supply chain, which
means the generic materials are known but nothing about the ingredients. Furthermore, packaging comes to the
market which is not designed for recycling. The main challenge lies in designing packaging which is appropriate
for continuous material flows, either making the materials suitable for returning safely and completely to the
biosphere or being recovered at a consistently high quality. Therefore, the implementation of a comprehensive
quality concept by positively defining ingredients and the subsequent input into (recycling) systems is
fundamental.
EPEA invites UNs supplier to adopt Cradle to Cradle Design as a tool to achieve Eco-effectiveness through the
application of established EPEA methods. To create the necessary framework for a paradigm shift, an
international organization for the design (thinking) of circular packaging solutions will be founded -
Page 4
What is the business case for green production in the market for global health aid?
Pac2Change. The association will be founded and launched in October 2014. Members will represent all parts of
the value chain and include commercial enterprises, government agencies, purchasers, producers and NGOs.
Members will be able to use the platform for innovation, co-creation, knowledge sharing and meeting purposes.
The organization will apply the Cradle to Cradle principles of the circular economy and the world's most
successful contemporary, iterative innovation process, Design Thinking.
What is the business case for green production in the market for global health aid?
PART 2: PANEL DISCUSSION - WHAT IS THE BUSINESS CASE FOR GREEN PRODUCTION IN THE MARKET
FOR GLOBAL HEALTH AID?
Moderated by: Dr. Christoph Hamelmann, HIV, Health and Development Team Leader for Europe and Central
Asia UNDP
Pan eli s t s:
Ms. Ruth Stringer, International Science and Policy Coordinator, Health Care Without Harm Europe
Ms. Victoria Elizabeth Stone-Bjarup, Responsible Sourcing Manager, Corporate Procurement, Novo
Nordisk A/S
Mr. Silas Holland, Lead, Tuberculosis Products Portfolio (Sourcing Department), The Global Fund to fight
aids, tuberculosis and malaria
Mr. Mukul Jerath, Deputy General Manager- Global TB, Lupin Limited
Ms. Oshani Perera, Programme Leader, Public Procurement and Infrastructure Finance, International
Institute for Sustainable Development
In tr o du c t ion b y D r. Ch r i st o ph Ha m e l man n
During the climate summit in New York City, occurring during the same week as the session, a coalition of
pharmaceutical companies and medical device manufacturers committed to certain activities which will
contribute to reducing the impact of greenhouse gas emissions. This showcases the on-going movement
towards increasing action-oriented activities in greening practices in the health sector, or that we are moving
towards more practical steps, leaving the public theatre of talking, but not doing (Dr. Christoph Hamelmann,
24th of September, UN City). The reason behind these efforts is the realization of the private and public business
case for greening production in the market for global health aid. Using public sector procurement as a tool for
change signals to all players that the UN system wants to reach out and have an inclusive engagement process
for greening the health sector.
Pan el D i sc u ss ion , pa rt 1
Question 1 (Q1): What are the benefits for various stakeholders (manufacturers, purchasers, financers) to get
engaged in this process?
Question 2 (Q2): What are the main obstacles in introducing greener production practices /regulations?
RUTH STRINGER, HEALTH CARE WITHOUT HARM (HCWH)
Q1: HCWH has an organizational mandate to greening the Health Sector, and procurement has been identified
to one key way to achieve this instead of waiting for regulations to enter into force. There is a clear business
case for greening production in the market for global health aid as the market for health care providers globally
is extremely large and thus the purchasing power strong.
Q2: The main obstacle is the lack of transparency regarding all components. Gaps in legislation on hazardous
chemicals are important, as it usually does not cover medical devices. This often arises due to competition on a
national level between the ministry of health and the ministry of environment.
Page 6
What is the business case for green production in the market for global health aid?
makes sense, not least as, in Novo Nordisk experience, being climate focused is also a driver for customer
satisfaction. High level engagement is key, it enables the opportunity for greater impact and in joining forces
Novo Nordisk creates new partnerships and business growth opportunities.
Q2: Transparency is critical, but there are also operational challenges to be overcome, in Novo Nordisk
experience theres a need to challenge the ways in which things have always been done, to foster a change in
mind-set and to ensure green objectives are part of business as usual.
Key words: partnerships create focus to improve; focus improves customer satisfaction; a change in mind-set is
needed to really make it work.
MORTEN SORENSEN, UNFPA
Q1: UNFPA is working closely with manufacturers in order to develop green procurement policies to encourage
greener production. They have been working with manufacturers on the production level, where suppliers have
engaged voluntarily, and at their own cost, to develop different options on how to optimise production, how to
reuse energy and water, etc. UNFPA is one of the biggest players in the procurement of reproductive health
products, and particularly in the procurement of condoms. They want to build partnerships in order to generate
positive engagement with manufacturers and suppliers.
Q2: The challenge will be to scale up existing initiatives with a product focus and to implement them into other
markets within the health sector industry. Joint efforts and long-term commitment will be essential, because
donors, financiers and procurers have to work together with suppliers and manufacturers to create an allinclusive positive engagement to greening production.
Articulating impact in terms of financial, health and moral costs among all stakeholder,
Ensuring standards to leverage purchasing power to drive safer, more environmentally sound products,
Developing clear policies and procedures for use and disposal of health care products and devices.
Key words: Purchasing power; standard qualification of services; long-term; well-being of population at large.
What is the business case for green production in the market for global health aid?
Key words: Process; Planning; Long-term engagement; Unforeseen obstacles; Financial implications
OSHANI PERERA, IISD
Q1: In green public procurement, the health sector is overlooked or forgotten. Health care for all is of vital
importance, but only if managed responsibly. The public owner has to be an entrepreneur, and set demands in
order to trigger innovation and eco-efficiency. Asking manufacturers to innovate without innovating
procurement is unfair and unviable.
Q2: Procurement exists in the back-office, but should be dealt with in the forefront. Strategies need to be
developed to design specifications and contract conditions. In other words, the design of procurement
processes need to be given more time and attention.
Key words: Entrepreneurialism in public sector; market power; design of procurement practices; high-level
decision making
Pan el D i sc u ss ion , pa rt 2
Question 3: What are the three most important criteria for the engagement process to be successful?
RUTH STRINGER: Connect multiple networks, provide clear specifications for manufacturers to know exactly
what is required, and give enough lead time, as manufacturers need 12-24 months to be able to deliver
products.
VICTORIA STONE-BJARUP : Be clear on what needs to be achieved, ensuring focus and investing in
partnerships, as Novo Nordisk experience shows, much more can be done when forces are joined.
MORTEN SORENSEN: Moving towards a common goal, for the manufacturers to have an incentive
(benefits/savings), and pre-qualifications that allow for manufacturers to put greening on their agenda.
SILAS HOLLAND: There is room for the public sector to become more entrepreneurial in the approach to
structuring sourcing mechanisms and working with manufacturers. Tenders should reflect organizational values
including environmental values beyond just price and lead time; this broader focus may enable win-win
situations where environmental values reduce costs.
MUKUL JERATH: Clear timeline, clear communication of requirements, and provision of help and motivation
(long-term engagement) to make these initiatives possible.
OSHANI PERERA: Contract criteria have to be established, as well as reward criteria to incentivize greener
processes. There has to be a triple win outcome, thus the health sector has to be reformed and redesigned to
become efficient and profitable. Shared risk is also an important criterion.
Page 8
What is the business case for green production in the market for global health aid?
The public sector needs to become an entrepreneur and step forward to provide leadership for
innovation
Ms. Oshani Perera, Programme Leader International Institute for Sustainable
Development, 24th of September 2014, UN City, Copenhagen
What is the business case for green production in the market for global health aid?
Ca s e p r es en ta ti on , C olo p la st
Presented by: Oluf Damsgaard Henriksen, Senior Climate Manager and Christoffer Quist Weesgaard, Corporate
Responsibility Manager
Coloplast develops products and services that make life easier for people with very personal and private medical
conditions. Their business includes ostomy care, urology & continence care and wound & skin care. Coloplast
categorizes their green initiatives within two main areas; Resources and energy including reduction of CO2
footprint and hazardous substances including reduction of toxicity of products and production processes.
(1) Resources and energy: To mitigate the total greenhouse gas emissions of Coloplast, focus is put on raw
materials, energy and transportation, which in total cover more than 80% of their total emissions. Within
raw materials, the company works extensively with the eco-design of products (life cycle assessments),
packaging and recycling of process waste. For energy efficiency, Coloplast works with factory design
and optimization. In this way, they lowered the CO2/unit from energy consumption significantly, thus
enabling
growth
while
reducing
CO2
emissions.
Within
transportation,
Coloplast
aims
to
minimize/eliminate the use of airfreight, which can have up to 200 times higher global warming
impact pr. unit transported than sea transportation, significantly reducing the overall impact from
distribution.
(2) Hazardous substances:
substances: Coloplast works to exclude the use of PVC/PVdC where possible, and has
eliminated the use of phthalates in new products. They have substitution programmes for existing
products furthermore and lobby for an international/EU ban against the use of phthalates in medical
devices. Other hazardous substances are evaluated according to REACH and on case by case by
Coloplasts bio-safety team.
Summary of Coloplasts input to the workshop discussion topics:
Q1: How can we move into the above direction and what can you as company offer from your side?
A1: We can develop step by step aligned with our competitors, but not take huge leaps without strong pull from
the market. Public and private purchasers should use their massive purchasing power to set strict sustainability
requirements teaming up in larger procurement associations makes sense for smaller purchasers. Customer is
king!
Q2: What prevents you to cooperate more closely within the sector on improving sustainability?
A2: Fierce competition in the sector driven by public and private tendering makes it very hard to cooperate on
sustainability topics, while at the same time competing on cost, quality and user experience in the market. It will
be beneficial to us, and the health care industry as such, if the UN could facilitate dialogue between competitors
in some constructive way that does not jeopardize competition between businesses.
Page 10
What is the business case for green production in the market for global health aid?
Q3: What would, in your view, facilitate a successful engagement process between the UN and you as business
partner in order to achieve the above goals?
A3: We are not currently doing business with the UN. However, as described in A1, our customers have the final
saying when it comes to sustainability. We can only drive the market to a limited extends, without pull from our
customers.
Q4. How can we continue these efforts after todays seminars (letter of intent, forum on sustainability,
presentation of your results on next years meetings)?
A4: We believe that todays seminar is a very good way of sharing our experiences and expertise with the UN.
Ca s e p r es en ta ti on , N ov o N or di sk
Presented by: Victoria Elizabeth Stone-Bjarup, Responsible Sourcing Project Manager, Corporate Procurement
Novo Nordisk is a global healthcare company specialised in diabetes and haemophilia care, growth hormone
therapy and hormone replacement therapy. Novo Nordisk believes that a healthy economy, environment and
society is fundamental to long-term business success. Therefore, they manage business in accordance with the
Triple Bottom Line business principle (being financially responsible, socially responsible and environmentally
responsible) and pursue business solutions that maximise value not only to their shareholders but to all
stakeholders. One example of how Novo Nordisk focuses on environmental issues is the partnership with Dong
Energy, through which Novo Nordisk addresses climate issues. The partnership was launched in 2007 and
builds on the following simple model:
DONG energy helps
Novo Nordisk save
energy at Danish
production sites
Novo Nordisk
implements energy
saving projects and
achieves financial
savings
Financial savings
earmarked to
purchase renewable
energy certificates
from wind farms
Electricity at Novo
Nordisks production
sites is covered by
renewable energy
certificates.
Since the partnership started, 370 energy-saving projects have been implemented. Examples of these projects
range from those classified as low-hanging fruits where changes such as ventilation adjustments at production
sites were made to realise energy savings through to larger-scale projects such as the heat recovery project,
which also resulted in significant savings. Through initiatives like these, Novo Nordisk has reached their 10%
CO2 absolute reduction target 5 years ahead of schedule, and has had cumulated net savings of 201 million
DKK with an average payback of 2.1 years. The partnership has proved that sustainability is commercially viable,
takes a long-term perspective, and creates value for the companies involved in the projects as well as for
society. As the Triple Bottom Line approach suggests, there is a business case in moving away from separate
sustainability strategies to rather incorporating the sustainability agenda in the overall strategy.
C on c lu si on s, g rou p di sc u s si on s
Backg
Background Information for group discussion
There will be a future engagement process with the UN system in which we want to obtain from our business
partners, as part of a commercial relation, actions with regard to:
What is the business case for green production in the market for global health aid?
GROUP RED
The discussions in this group were framed within the lens of the Novo Nordisk legacy of management of a triple
bottom approach, entailing an integration of sustainability strategies at a high level. Discussions encouraged
framing of possibilities and focus on low-hanging fruits. Furthermore, the group stressed the importance of
clear communication around potential venues for cooperation as well as the need for a common language and
common standards.
Question
Conclusions of discussions
side?
Someone from within the buying sector who can speak the
supplier-language
GROUP BLUE
The groups discussion took a starting point in purchasing power and customer demand. The transition towards
greener production methods has to be initiated by procurers, in this context by the public procurers for global
health aid. However, the discussions also emphasized the importance of involving the market in the dialogue, as
the expertise possessed by suppliers regarding production processes are vital to understand different
implications and to be successful with green initiatives.
Questions
Conclusions of discussions
side?
Page 12
What is the business case for green production in the market for global health aid?
programme.
GROUP GREEN
The discussions in this group revolved around expectations and feasibility. Expectations should be clearly
expressed: however, there is a need to understand the different characters of different products, and that all
cannot be included under the same methodology. Therefore, it is important to include suppliers in the
development of criteria, as they are the true experts of the production process. Furthermore, there is a need to
standardize language and methodologies around environmental assessment and find a common agreement on
how to measure initiatives.
Questions
Conclusions of discussions
side?
Realistic timeline
Know the production process, the manufacturers have the
expertise
products.
Capacity building.
Guideline processes
On-going dialogue.
What is the business case for green production in the market for global health aid?
CONCLUDING REMARKS
As a result of the many contributions from the different participants of the session, several outcomes could be
identified that create a roadmap for continued work. Overall, there was a great consensus on the need for
immediate action for sustainability within the market for global health aid. Focus was on the significance of joint
efforts as well as on the importance to create frameworks for innovation. Initiatives should be undertaken by
procurement agencies and financing institutions so that purchasing power is used as a tool for change.
Moreover, suppliers and manufacturers should be included in the dialogue from the start in order to develop
bottom-up approaches to greening production in the market for global health aid.
The following conclusions can be drawn from the working session:
UN suppliers of pharmaceuticals and medical devices are ready to become involved in pilot projects on ecoecoinnovation:
innovation: The Stockholm International Water institute together with their partner cKinetics introduced a
methodology on water and energy efficiency, and gave proof of already successfully implemented projects in the
textile industry. Suppliers of the working session were encouraged to get involved in pilot projects: simple
questionnaires were distributed during the session and several suppliers showed interest to become involved,
both during the workshop as well as by attending side-meetings outside of the session.
Suppliers are willing to develop ecoeco-innovative products and to work with the UN and other procurement
agencies towards tender processes that take environmental aspects into consideration: During the workshop, it
was stated that existing frameworks, more specifically prequalification requirements and tender documents,
inhibit suppliers ability to innovate for green solutions. Therefore, in order to encourage green initiatives, these
public procurement regulations need to be reshaped to encourage eco-innovation among suppliers and
manufacturers.
Procurement agencies and financing institutions recognize the importance of the Joint UN Programme on
and
nd committing to
Greening Procurement in the Health Sector and will show their full support by encouraging a
activities proposed by the Secretariat: As several projects will be undertaken in the near future by the Secretariat
for the Joint UN Programme on Greening Procurement in the Health Sector, it will be central to have leading
procurement agencies and financing institutions on board. The Secretariat has met considerable interest from
different stakeholders and has noticed a willingness among these to engage in proposed activities.
There is an overall consensus among actors to continue the dialogue
dialogue as soon as possible and to identify
structured forms of engagement for greening production within the market for global health aid: In conclusion,
all participants agreed on the importance of taking actions within the near future to green practices in the
market for global health aid. Participants of the working session recognized that the approach of the Joint UN
Programme on Greening Procurement in the Health Sector is realistic in order to achieve this. However, they also
emphasized the importance of linking the Joint UN Programme to other global initiatives in the field of
sustainability.
Page 14
What is the business case for green production in the market for global health aid?
FUTURE ACTIONS
The third output of the Joint UN Programme for Greening Procurement in the Health Sector targets social
outreach and dialogue. More specifically, output 3 states: Key stakeholders with an influence over procurement
activities in the health sector, e.g. suppliers/manufacturers, procurement officers, international health
development agencies, and health actors, are engaged in and supportive of the overall initiative. We consider
that the outcome of this working session can be used as a start for this dialogue and we therefore suggest that
the Secretariat for the Joint UN Programme on Greening Procurement in the Health Sector after consultation with
the steering committee initiates follow-up activities.
An outline of possible activities will be:
Analyze and assess existing prequalification schemes and tender documents in order to suggest
changes that can reduce regulatory bottlenecks and encourage business model innovation for
sustainability;
As suggested during the working session, a workshop will be planned in Asia to continue the dialogue
with suppliers and manufacturers on greening practices within the Health Sector;
The feasibility of pilot projects with suppliers, in collaboration with Stockholm International Water
Institute or the Centre for Sustainable Consumption and Production (SCP), will be analyzed;
The Secretariat for the Joint UN Programme on Greening Procurement in the Health Sector intends to
involve parties of the working session in the future elaboration of the Green Procurement Index2 as
interest was found.
What is the business case for green production in the market for global health aid?
LINKS
Related topics:
http://www.slideshare.net/undpeuropeandcis/greening-the-health-sector-global-health-initiatives-andclimate-change
http://www.slideshare.net/undpeuropeandcis/greening-the-health-sector-pharmaceuticals-and-climatechange
http://www.eurasia.undp.org/content/rbec/en/home/library/hiv_aids/rapid-assessment-healthcare-wasteglobal-fund/
http://www.undp.org/content/undp/en/home/librarypage/hiv-aids/managing-our-climate-change-risk--anapproach-for-environmental-.html
http://www.scribd.com/doc/173048077/Carbon-footprint-of-UNDP-Global-Fund-health-initiatives-inMontenegro-and-Tajikistan
http://www.unfpa.org/webdav/site/global/shared/procurement/08_QA/Green%20Procurement%20Strategy_NO
V%202013%20last_compressed.pdf
http://www.unfpa.org/webdav/site/global/shared/procurement/08_QA/Safe%20Disposal%20and%20Manageme
nt%20of%20Unused%20Unwanted%20Contraceptives.pdf
Page 16
APPENDIX 1. AGENDA
What is the business case for green production in the market for global health aid? - Agenda
Organiser: IIATT-SPHS Secretariat
Wednesday 24th September 2014, UN City, Auditorium I
14.30 - 15.30 PRESENTATIONS
Chaired by: Pauline Gthberg
14.30 - 14.35 Welcome address
14.35 - 14.40 Roads to Transformational Partnership
14.40 - 14.55 Methodology for limiting water use in the production of
pharmaceuticals
14.55 - 15.10 Cradle to Cradle
15.10 - 15.25 Joint UN Programme: Greening Procurement in the Health
Sector
15.30 - 16.00 Coffee/tea break
16.00 - 17.00 PANEL DISCUSSION:
Chaired by: Dr Christoph Hamelmann
16.00 - 16.05 Introduction
16.05 - 17.00 Panel Discussion: What is the business case for green
production in the market for global health aid?
Pauline Gthberg
Pernille Fenger
Charlotte Khler Lindahl
Dr Pawan Mehra
Ingo Walterscheid
Volker Welter
Dr Christoph Hamelmann
Ruth Stringer
Victoria Elizabeth Stone-Bjarup
Morten Sorensen
Silas Holland
Mikul Jerath
Oshani Perera
HIV, Health and development Practice Leader for Europe and Central Asia, UNDP
Science and Policy Coordinator, Health Care Without Harm Europe
Responsible Sourcing Manager, Corporate Procurement, Novo Nordisk A/S
Deputy Chief of Procurement, UNFPA
Lead, TB Products Portfolio (Sourcing Department), The Global Fund
Dy. General Manager- Global TB, Lupin Pharma
Programme Leader, Public Procurement and Infrastructure Finance, International Institute for Sustainable Development
Mohammad Asim
Martin Hansen
What is the business case for green production in the market for global health aid? - Participant list
Organiser: IIATT-SPHS Secretariat
Participant
Position
Facilitators
Swedish County
Pauline Gthberg
National coordinator
and Speakers
Programme Manager
Institute
Nicolai Schaaf
Programme Officer
cKinetics
Dr Pawan Mehra
Managing Director
Environmental
Ingo Walterscheid
CEO
Oshani Perera
Stockholm
International Water
Protection
Encouragement
Agency
International Institute
for Sustainable
Development
Finance
Ruth Stringer
Martin Hansen
Consultant
Mohammad Asim
Consultant
Ashley Jackson
Harm Europe
Implement Consulting
Group
Compliance
Silas Holland
UN Staff
UNFPA
UNDP
Pernille Fenger
Morten Sorensen
Chief PSB
Ignacio Diaz
Project Coordinator
Camilla Brckner
What is the business case for green production in the market for global health aid?
Christoph Hamelmann
Other
Volker Welter
Padcha Panichgul
Procurement Analyst
Pranisha Bajracharya
Programme Associate
Mirjana Milic
Communications Associate
Rachel Bagnall
iIATT-SPHS Assistant
Katharina Kjoege
iIATT-SPHS Assistant
Karin Lonaeus
iIATT-SPHS Assistant
Hanne Juel
Civil Servant
Dorte Christensen
Ebbe Abildgaard
Thomas Mller
Environmental Coordinator
Henrik Jensen
Associate Partner
Peter Bernstorff
Founder
Sara Bernstorff
Founder
Fairtrade Denmark
Jonas Giersing
Director
Environmental
Christian Dinter
Tom Ohlendorf
Packaging engineer
Emma Hjern
Lupin
Mukul Jerath
Pfizer
Daniele Russo
Central Denmark
Region
Copenhagen Institute
for Futures Studies
Noble Consulting
Protection
Encouragement
Agency
Danish Ministry of
Foreign Affairs
UN Suppliers
Health Institutions
Svizera
Managing Director
Cepheid
Hallie Lewis
What is the business case for green production in the market for global health aid?
Bayer
Jean-Francois Fiard
BD
Laurent Dini
Wolfgang Becker-Jezuita
Director
Jean-Franois Mathieu
Brigitte Cornelis
Cipla
Vaishali Shridhankar
Group Leader
Mylan Laboratories
Varun Razdan
Hetero
Arvind Kanda
Namrata Vyas
Karex
Amy Goh
Sales Director
Innolatex
Paul Liang
CEO
MSD
Pregna
Famycare
Business Coordinator
Ramesh Taparia
Managing Director
Jaykumar Kabra
Export Manager
Jitesh Prabhu
Harikrishnan Namboothiri
Krishna Jadhav
NonNon-UN
Suppliers
Corporate Procurement
Coloplast
Page 2
CSR manager
Oluf Damsgaard
What is the business case for green production in the market for global health aid?
UNDP
Dr. Christoph Hamelmann, HIV, Health and Development Team Leader for Europe and Central Asia, UNDP
christoph.hamelmann@undp.org
Volker Welter, Senior Procurement Adviser
Tel: +45 4533 6050 I E-mail: volker.welter@undp.org
Mirjana Milic, Communications Associate
Tel: +45 4533 6068 I E-mail: mirjana.milic@undp.org
UNFPA
Morten Sorensen, Deputy Chief PSB
Tel: +45 4533 7222 I E-mail: sorensen@unfpa.org
Ignacio Sanchez Diaz, Project Coordinator
Tel: +45 4533 7247 I E-mail: idiaz@unfpa.org